Freshpet’s latest earnings shift focus to growth quality and cash generation

Freshpet (FRPT) recently reported quarterly results that included surpassing US$1b in net sales for the first time, beating analysts’ adjusted operating income estimates, and reporting positive free cash flow.

Management also highlighted expanded margins alongside these results. The share price has pulled back since the report, giving investors a fresh set of financial markers to weigh against Freshpet’s longer term performance and valuation.

Freshpet’s recent pullback sits against a mixed performance picture, with a 9.66% year to date share price return but an 11.01% decline in 1 year total shareholder return. This suggests momentum has cooled even as recent earnings improved sentiment.

If Freshpet’s update has you thinking about where growth stories might come from next, it could be worth scanning other potential opportunities using the 19 top founder-led companies

With Freshpet now generating over US$1b in annual net sales, positive free cash flow, and a pullback after earnings, the key question is whether the recent weakness signals a mispriced growth story or a market already banking on future gains.

Most Popular Narrative: 24.1% Undervalued

Freshpet's most followed valuation narrative places fair value at about $86.93 per share, compared with the latest close at $65.96, putting the focus firmly on margins and cash generation.

Operational improvements and implementation of new production technologies at Ennis and other facilities have driven higher yields, quality, and throughput, leading to a significant reduction in CapEx ($100 million less over 2025-26) and enhanced gross/EBITDA margins, setting the business up for improving net earnings and cash generation.

Want to see what kind of revenue growth, margin lift, and earnings profile are baked into that gap between price and fair value? The narrative leans on a specific path for volume, pricing, and operating leverage that is far from generic consumer staples thinking. Curious how those assumptions stack up against the recent pullback and current analyst spread on future earnings and multiples? The full story connects those moving parts into one valuation bridge.

Result: Fair Value of $86.93 (UNDERVALUED)

However, this hinges on premium pet food demand and category growth holding up, with slower pet adoption and rising competition both capable of undermining that margin-focused narrative.

Another View: Valuation Signal From Earnings Multiples

The fair value narrative leans on discounted future cash flows, but the current P/E ratio of about 23.3x tells a different story. It sits above the US Food industry at 21x, above peers at 17.8x, and above a fair ratio of 13.5x. This points to clear valuation risk if expectations ease.

For investors weighing that richer earnings multiple against the DCF based undervaluation case, the key question is which yardstick will matter more as Freshpet’s growth and margins settle.

Next Steps

With sentiment clearly split between opportunity and risk, this is the moment to review the details yourself and decide where you stand. Start with the 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Freshpet has sharpened your thinking, do not stop here. Broaden your watchlist with a few focused stock ideas that could sharpen your next move.

• Target resilient income by scanning companies that show up as 13 dividend fortresses and see which payouts might suit your goals.
• Spot quality at a potential discount by reviewing the 61 high quality undervalued stocks and compare how their fundamentals line up with your expectations.
• Stay on the front foot by checking the 73 resilient stocks with low risk scores and see which names could help balance out bolder positions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.